JP2023515565A5 - - Google Patents
Info
- Publication number
- JP2023515565A5 JP2023515565A5 JP2022551040A JP2022551040A JP2023515565A5 JP 2023515565 A5 JP2023515565 A5 JP 2023515565A5 JP 2022551040 A JP2022551040 A JP 2022551040A JP 2022551040 A JP2022551040 A JP 2022551040A JP 2023515565 A5 JP2023515565 A5 JP 2023515565A5
- Authority
- JP
- Japan
- Prior art keywords
- aryl
- heteroaryl
- cancer
- alkyl
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062981418P | 2020-02-25 | 2020-02-25 | |
| US62/981,418 | 2020-02-25 | ||
| US202163139262P | 2021-01-19 | 2021-01-19 | |
| US63/139,262 | 2021-01-19 | ||
| PCT/EP2021/054559 WO2021170658A1 (en) | 2020-02-25 | 2021-02-24 | Heterocyclic compounds for modulating nr2f6 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023515565A JP2023515565A (ja) | 2023-04-13 |
| JP2023515565A5 true JP2023515565A5 (cg-RX-API-DMAC7.html) | 2024-02-29 |
Family
ID=74797908
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022551040A Pending JP2023515565A (ja) | 2020-02-25 | 2021-02-24 | Ｎｒ２ｆ６を調節する複素環式化合物 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20220213061A9 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4110758A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2023515565A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20220158228A (cg-RX-API-DMAC7.html) |
| CN (2) | CN118878514A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021226974A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112022016941A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3167785A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL295456B1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2022010456A (cg-RX-API-DMAC7.html) |
| TW (1) | TW202140447A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021170658A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023042914A1 (en) * | 2021-09-17 | 2023-03-23 | Otsuka Pharmaceutical Co., Ltd. | Pyrrolidine compounds as histone deacetylase inhibitors |
| WO2025106383A1 (en) * | 2023-11-17 | 2025-05-22 | Merck Sharp & Dohme Llc | Pyrrolidinyl derivatives useful as hcn1/hcn 2 modulators |
| KR20250173438A (ko) * | 2024-05-30 | 2025-12-10 | 삼진제약주식회사 | Nr2f6 억제제 및 이의 용도 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20040094806A (ko) * | 2002-03-18 | 2004-11-10 | 교린 세이야꾸 가부시키 가이샤 | 내성균에 유효한10-(3-시클로프로필아미노메틸-1-피로리디닐)피리도벤즈옥사진 카르본산 유도체 |
| WO2005016000A1 (en) * | 2003-08-05 | 2005-02-24 | Avalon Pharmaceuticals | Derivatives of cyclic quinone and uses thereof |
| US7138423B2 (en) * | 2004-07-20 | 2006-11-21 | Bristol-Myers Squibb Company | Arylpyrrolidine derivatives as NK-1 /SSRI antagonists |
| EP1957450B1 (en) * | 2005-12-01 | 2009-06-24 | F.Hoffmann-La Roche Ag | Serotonin transporter (sert) inhibitors |
| JP2011507850A (ja) * | 2007-12-21 | 2011-03-10 | ザ スクリプス リサーチ インスティチュート | Ｒｈｏキナーゼインヒビターとしてのアニリドおよびアナログ |
| US8450344B2 (en) * | 2008-07-25 | 2013-05-28 | Aerie Pharmaceuticals, Inc. | Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds |
| WO2010024903A1 (en) * | 2008-08-29 | 2010-03-04 | Yangbo Feng | BENZO[d]OXAZOLES AND BENZO[d]THIAZOLES AS KINASE INHIBITORS |
| WO2010059922A1 (en) * | 2008-11-21 | 2010-05-27 | Ligand Pharmaceuticals Incorporated | Pyrrolidine carboxamide compounds |
| WO2015070170A1 (en) * | 2013-11-08 | 2015-05-14 | The Translational Genomics Research Institute | Compounds for cognitive enhancement and methods of use thereof |
| US10472351B2 (en) * | 2016-07-18 | 2019-11-12 | Zander Therapeutics, Inc. | Small molecule agonists and antagonists of NR2F6 activity in animals |
| US11324719B2 (en) * | 2016-07-18 | 2022-05-10 | Kcl Therapeutics, Inc. | Small molecule agonists and antagonists of NR2F6 activity in humans |
| CN107674013B (zh) * | 2016-08-02 | 2022-05-24 | 上海迪诺医药科技有限公司 | 多环化合物、其制备方法、药物组合物及应用 |
| AU2018221148B2 (en) * | 2017-02-17 | 2022-05-05 | Trevena, Inc. | 5-membered aza-heterocyclic containing delta-opioid receptor modulating compounds, methods of using and making the same |
| CN110776521A (zh) * | 2019-10-24 | 2020-02-11 | 秦源生物医药科技(上海)有限公司 | 一种1,2,4-三唑-1,3,4-噻二唑类化合物及其应用 |
-
2021
- 2021-02-24 EP EP21708591.9A patent/EP4110758A1/en active Pending
- 2021-02-24 KR KR1020227031938A patent/KR20220158228A/ko active Pending
- 2021-02-24 CN CN202410447842.5A patent/CN118878514A/zh active Pending
- 2021-02-24 BR BR112022016941A patent/BR112022016941A2/pt unknown
- 2021-02-24 US US17/184,431 patent/US20220213061A9/en active Pending
- 2021-02-24 IL IL295456A patent/IL295456B1/en unknown
- 2021-02-24 CA CA3167785A patent/CA3167785A1/en active Pending
- 2021-02-24 MX MX2022010456A patent/MX2022010456A/es unknown
- 2021-02-24 CN CN202180029911.5A patent/CN115427394A/zh active Pending
- 2021-02-24 JP JP2022551040A patent/JP2023515565A/ja active Pending
- 2021-02-24 TW TW110106395A patent/TW202140447A/zh unknown
- 2021-02-24 AU AU2021226974A patent/AU2021226974A1/en active Pending
- 2021-02-24 WO PCT/EP2021/054559 patent/WO2021170658A1/en not_active Ceased